Pneumonia News and Research

Latest Pneumonia News and Research

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough announced that data on boceprevir, an investigational hepatitis C virus (HCV) protease inhibitor, will be reported in an oral presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston, Oct. 30-Nov. 3.

19 Oct 2009

Genentech reports results of ACTEMRA Phase III study for rheumatoid arthritis

Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).

19 Oct 2009

Readmission of elderly patients after colectomy strongly linked with mortality: Study

Readmission to a hospital after standard surgical treatment for colon cancer is far more common than suspected for elderly patients according to researchers who presented their findings at the 2009 Clinical Congress of the American College of Surgeons. Results from the first study to determine nationwide readmission rates following colectomy [surgical removal of malignant disease and part of the colon] in the Medicare population revealed that nearly one in nine patients over the age of 65 was readmitted within 30 days.

19 Oct 2009

Slow start for PSOs meant to help providers learn from mistakes

A federal agency has designated 68 "Patient Safety Organizations" to offer health care providers a way "to share information and learn from problems," Modern Healthcare reports. But, a year after the Agency for Healthcare Research and Quality began implementing the program, its "technology has not been finessed enough to really enable that sharing."

19 Oct 2009

Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes launched by Covidien

Covidien, a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, today announced the global launch of Mallinckrodt™ TaperGuard™ and TaperGuard™ Evac endotracheal tubes.

19 Oct 2009

Aurora Visiting Nurse Association to suspend its seasonal flu vaccination clinics

Delays in shipments from vaccine manufacturers will force the Aurora Visiting Nurse Association of Wisconsin to suspend its seasonal flu vaccination clinics throughout eastern Wisconsin.

19 Oct 2009

UNICEF and WHO call for an urgent plan to control diarrheal disease

The United Nations Children’s Fund (UNICEF) and World Health Organization (WHO) released a joint report today demonstrating the urgent need to focus attention on diarrheal disease, a neglected illness responsible for the deaths of about 1.5 million children under 5 each year. This unacceptable loss of life can be stopped.

15 Oct 2009

Fero Industries to acquire Pyro Pharmaceuticals

Fero Industries, Inc. (the “Company”) is pleased to announce that the Company has entered into a Definitive Agreement to acquire Pyro Pharmaceuticals, Inc. of Irvine, California.

15 Oct 2009

Women with breast cancer can improve their mental health through Transcendental Meditation technique

Women with breast cancer reduced stress and improved their mental health and emotional well being through the Transcendental Meditation technique, according to a new study published in the current issue of the peer-reviewed Integrative Cancer Therapies (Vol. 8, No. 3: September 2009).

14 Oct 2009

NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research

Novavax, Inc. announced today that it has received a Small Business and Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The grant from the NIAID is to support a segment of the Company's preclinical research program for the respiratory syncytial virus (RSV) particle-based vaccine.

14 Oct 2009

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.

14 Oct 2009

Patients at highly rated hospitals have a 52% lower chance of dying: Study

The largest annual study of patient outcomes at each of the nation’s 5,000 nonfederal hospitals found a wide gap in quality between the nation’s best hospitals and all others. According to the study, issued today by HealthGrades, the leading independent healthcare ratings organization, patients at highly rated hospitals have a 52 percent lower chance of dying compared with the U.S. hospital average, a quality chasm that has persisted for the last decade even as mortality rates, in general, have declined.

14 Oct 2009

Sequella receives Phase 1 SBIR grant for developing SQ641

Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.

13 Oct 2009

Sonitus Medical’s SoundBite hearing system ranks first on Top 10 Medical Innovations for 2010

Sonitus Medical, Inc., a medical device company developing the world's first non-surgical and removable hearing device to transmit sound via the teeth, today announced that technology it developed was ranked #1 on Cleveland Clinic's Top 10 Medical Innovations for 2010.

13 Oct 2009

Good Samaritan Hospital tops HealthGrade ratings for stroke treatment and joint replacement

A study issued today by HealthGrades, Inc., the leading independent healthcare ratings organization, finds that Good Samaritan Hospital is among the Top 5% in the Nation for Treatment of Stroke and Top 10% in the Nation for Joint Replacement. The nation’s nearly 5,000 nonfederal hospitals were all included in the sweeping study, which examined mortality rates and complication rates from government data from 2006, 2007 and 2008.

13 Oct 2009

Patient outcomes better in highly rated hospitals than others

The largest annual study of patient outcomes at each of the nation's 5,000 nonfederal hospitals found a wide gap in quality between the nation's best hospitals and all others. According to the study, issued today by HealthGrades, the leading independent healthcare ratings organization, patients at highly rated hospitals have a 52 percent lower chance of dying compared with the U.S. hospital average, a quality chasm that has persisted for the last decade even as mortality rates, in general, have declined.

13 Oct 2009

Recent releases in Global Health

A Lancet comment examines an Affordable Medicines Facility for malaria (AMFm) program to help countries procure subsidized artemisinin-based combination treatments (ACTs).

9 Oct 2009

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

A comprehensive study has revealed, for the first time, the impact of swine flu on the health of the general public in Australia and New Zealand.

9 Oct 2009

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.

9 Oct 2009

Persistent, growing disparities underscore the need for national reform

The cost and quality of health care, as well as access to care and health outcomes, continue to vary widely among states, according to the Commonwealth Fund Commission on a High Performance Health System's second state scorecard report released today.

9 Oct 2009

Pneumonia News and Research

Latest Pneumonia News and Research

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Genentech reports results of ACTEMRA Phase III study for rheumatoid arthritis

Readmission of elderly patients after colectomy strongly linked with mortality: Study

Slow start for PSOs meant to help providers learn from mistakes

Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes launched by Covidien

Aurora Visiting Nurse Association to suspend its seasonal flu vaccination clinics

UNICEF and WHO call for an urgent plan to control diarrheal disease

Fero Industries to acquire Pyro Pharmaceuticals

Women with breast cancer can improve their mental health through Transcendental Meditation technique

NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Patients at highly rated hospitals have a 52% lower chance of dying: Study

Sequella receives Phase 1 SBIR grant for developing SQ641

Sonitus Medical’s SoundBite hearing system ranks first on Top 10 Medical Innovations for 2010

Good Samaritan Hospital tops HealthGrade ratings for stroke treatment and joint replacement

Patient outcomes better in highly rated hospitals than others

Recent releases in Global Health

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

Persistent, growing disparities underscore the need for national reform

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Pneumonia News and Research

Latest Pneumonia News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in